Actively Recruiting

Phase 2
Age: 18Years - 80Years
All Genders
NCT07298343

Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease

Led by Dr. Falk Pharma GmbH · Updated on 2026-04-02

356

Participants Needed

1

Research Sites

163 weeks

Total Duration

On this page

Sponsors

D

Dr. Falk Pharma GmbH

Lead Sponsor

T

Takeda Development Center Americas, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet

CONDITIONS

Official Title

Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent
  • Men or women between 18 and 80 years of age, inclusively
  • Documented initial biopsy-proven diagnosis of celiac disease or, if no biopsy, TG2-IgA > 10 x upper limit of normal at diagnosis at least 12 months prior
  • Adherence to a gluten-free diet for at least 12 months prior
  • Human leukocyte antigen DQ typing compatible with celiac disease
Not Eligible

You will not qualify if you...

  • Presence of hypo- or hyperthyroidism unless well controlled for the previous 3 months
  • Confirmed refractory celiac disease type I or II, except type I without signs of T cell monoclonality or atypical T cells, no severe symptoms, and no prior immunosuppressant treatment
  • Severe complications of celiac disease
  • Other intestinal diseases such as Crohn's, ulcerative colitis, severe IBS, microscopic colitis, SIBO, exocrine pancreatic insufficiency, or other active intestinal diseases interfering with symptom assessment
  • History or presence of dermatitis herpetiformis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Medical Center Mainz

Mainz, Germany

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

5

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here